Our goal is to facilitate bench–to–bed translation and help translate insights into novel bio–therapeutics. Our state–of–the–art cGMP facility offers to manufacture of bio–therapeutics for safety and initial efficacy testing in first–in–human, pilot, and Phase I/II clinical trials.